News >

Shields Sheds Light on Complex mCRC Landscape

Brandon Scalea
Published: Thursday, May 16, 2019

Anthony Shields, MD, PhD

Anthony Shields, MD, PhD

Immunotherapy and targeted therapy have shown promise in the treatment of select subsets of patients with metastatic colorectal cancer (mCRC) who harbor genetic alterations, but the question of whether this benefit can be extended into a broader patient population remains unanswered, said Anthony Shields, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication